Toggle Offcanvas
...
 
抗血栓剂招标

抗血栓剂招标

查看抗血栓剂的招标,RFP和合同。自2002年以来,竞标具有最佳,最全面的招标平台的随时可用的抗血栓形式。 竞标抗血栓形成剂的招标对于各种规模的公司来说是极为有利可图的。招标当局和私人公司释放了数千份价值数百万美元的合同,用于采购抗血栓药。

全球招标是致力于招标和政府合同的最大平台。全球台人拥有超过20年的招标业务经验,提供了最广泛,最可靠的招标/RFP/合同数据库。该平台汇总了公共和私人资源的合同,与超过50万买家的庞大网络建立了联系。我们细致的过程采用了先进的人工智能,涉及从十万来源收集信息。然后,将数据智能分类为数千个子类别,以方便过滤并以用户友好的格式显示,以快速理解。

除了招标信息外,我们还提供深入的抗强化代理市场分析,出价咨询服务以及对高价竞标者和优胜者的见解。 立即注册以立即访问无限制的抗血栓剂招标,高级搜索过滤器,市场分析,行业趋势,招标培训和24/7客户支持。

15 Live Notices for 抗血栓剂招标

Showing 1 to 15

Medicinal Products Containing Antithrombin Iii
country Czech Republic
posting date09 Dec 2024
deadline08 Jan 2025
MEDICINES
country Bosnia and Herzegovina
posting date03 Dec 2024
deadline18 Dec 2024
Sale And Delivery Of Medicinal Products And Medical Devices For The Needs Of The Edmund Biernacki Specialist Hospital In Mielec
country Poland
posting date02 Dec 2024
deadline08 Jan 2025
Supply Of Hbpm Medications For Establishments Of The Territory Hospital Group 49 - Ao Ghtao-2025
country France
posting date26 Nov 2024
deadline27 Dec 2024
Supply Of Hbpm Medicines For Establishments Of The Territory Hospital Group 49 - Ao Ghtao-2025
country France
posting date25 Nov 2024
deadline27 Dec 2024
Supply Of Hbpm Medications For Establishments Of The Territory Hospital Group 49 - Ao Ghtao-2025
country France
posting date25 Nov 2024
deadline27 Dec 2024
Supply Of Hbpm Medications For Establishments Of The Territory Hospital Group 49 - Ao Ghtao-2025
country France
posting date25 Nov 2024
deadline27 Dec 2024
Tenecteplase
country Lithuania
posting date10 Oct 2024
deadline10 Oct 2025
Prior Information Notice: Antithrombotic Agents, Blood Substitutes And Perfusion Solutions And Antihemorrhagics
country Finland
posting date21 Sep 2024
deadline20 Sep 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V Of The Consultation Hours Requirement In Lower Saxony For Prescription And Dispensable Medicines With The Active Ingredient Enoxaparin (Atc B01Ab05)
country Germany
posting date16 Oct 2023
deadline27 Sep 2025
Dk 021:2015- 33600000-6 Pharmaceutical Products, Dk 021:2015:33620000-2 Medicinal Products For The Treatment Of Blood Diseases, Blood-Forming Organs And Diseases Of The Cardiovascular System (33621100-0 Antithrombotic Agents) Actylize®. Lyophilisate For Solution For Infusions, 50 Mg, In 1 Vial With Solvent … More
country Ukraine
posting date17 Dec 2024
deadline20 Dec 2024
Dk 021:2015- 33600000-6 Pharmaceutical Products, Dk 021:2015:33620000-2 Medicinal Products For The Treatment Of Blood Diseases, Blood-Forming Organs And Diseases Of The Cardiovascular System (33621100-0 Antithrombotic Agents) Actylize®. Lyophilisate For Solution For Infusions, 50 Mg, In 1 Vial With Solvent … More
country Ukraine
posting date16 Dec 2024
deadline31 Dec 2024
Dk 021:2015- 33600000-6 Pharmaceutical Products, Dk 021:2015:33620000-2 Medicinal Products For The Treatment Of Blood Diseases, Blood-Forming Organs And Diseases Of The Cardiovascular System (33621100-0 Antithrombotic Agents) Actylize®. Lyophilisate For Solution For Infusions, 50 Mg, In 1 Vial With Solvent … More
country Ukraine
posting date14 Dec 2024
deadline28 Dec 2024
Pharmaceutical Products, Code 33600000-6 According To Dk 021:2015 "Unified Purchasing Dictionary"
country Ukraine
posting date28 Sep 2024
deadline27 Sep 2025
Pharmaceutical Products Code 33600000-6 According To Dk 021:2015 "Unified Purchasing Dictionary" (Gelatin Agents - Code 33620000-2 According To Dk 021:2015 "Unified Purchasing Dictionary" - Medicinal Products For The Treatment Of Diseases Of The Blood, Hematopoietic Organs And Diseases Of The Cardiovascular System ; Enoxaparin - Code 33621100-0 According To Dk 021:2015 - Antithrombotic Agents - Code 33620000-2 According To Dk 021:2015 Medicines For The Treatment Of Diseases Of The Blood, Blood-Forming Organs And Cardiovascular System - Code 33621200- 1 According To Dk 021:2015 Hemostatic Agents; Mannitol - Code 33621400-3 According To Dk 021:2015 Blood Substitutes And Perfusion Solutions)
country Ukraine
posting date04 Jul 2024
deadline02 Jul 2025

Share Share this page